FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W177056526> ?p ?o ?g. }

• W177056526 abstract "Abstract The efficacy of induction chemotherapy in childhood acute lymphoblastic leukemia (ALL) is usually evaluated on day 35. However, at this stage, many patients have already begun to recover and present with a regenerative bone marrow (BM) where hematogones may make the identification of residual blast cells problematic both in morphology and in flow cytometry (FCM). In the FRALLE (French Acute Lymphoblastic Leukemia) trials, evaluation is proposed on days 8, 21 and 35. Here we evaluated whether FCM performed on day 21 (D21), when hematogones are still absent, would prove informative. The cohort reported here was constituted of 45 children aged between 1 and 20 years old (median 6) treated for ALL according to the FRALLE recommendations since 2006. There were 81% B-ALL, 17% T-ALL and 2% of mixed phenotype acute leukemia (MPAL, T/My). At diagnosis, the mean percentage of BM blasts was 50%. Classification according to the European Group for Immunophenotyping of Leukemia (EGIL) was 3 B-I, 21 B-II, 11 B-III, 2 B-IV and 1 T-I, 2 T-II and 4 T-III. Extensive immunophenotyping at diagnosis identified a median of 3 leukemia associated immunophenotypes (LAIP, range 1-5), defined as discriminant from hematogones. Corticosensitivity was defined on a complete blood count (CBC) as less than 1 G/L of blast cells on day 8. Chemosensitivity was assessed on a bone marrow aspiration at day 21, both morphologically (< 5% blasts) and in FCM (MRD0). Molecular biology (according to Biomed2) was performed on BM samples collected on days 35 (MRD1) and 70 (MRD2). Follow-up median time was 59 months (3-276). Corticosensitivity was observed for 39/43 patients (one had received corticosteroids for a tonsillitis before being referred and diagnosed with ALL and another one had less than 1 G/L of blasts at diagnosis). Five/44 patients were identified as chemoresistant by morphology on D21 (one aplastic sample). Enough cells were available for minimal residual disease (MRD) by FCM in 43 patients, on bone marrow collected on EDTA. As a mean, 586 328 total nucleated cells were acquired in FCM (range 9 616 - 1 751 000) thereby providing good sensitivity. Multiparameter FCM in 6 to 8 colors was performed on a single tube, customized according to each patient’s LAIP. Five MRD thresholds were defined as follows : level 1, >10-2 detected blasts; level 2, 10-3- <10-2detected blasts; level 3, 10-4- <10-3detected blasts; level 4, 10-5- <10-4 detected blasts or no event detected; level 5, <10-5detected blasts or no event detected. The table below indicates the partition of patients according to these MRD levels on D21. Table 1LevelPatient numbersDetectable MRDAbsence of MRD166028803660415695818 Event-free survival (EFS; Kaplan Meier Log rank test) was statistically significant (p=0.023) when comparing patients with level 4 or 5 MRD to the others. Level 3 patients had an intermediate EFS and OS. In an independent cohort of 79 patients with evaluable FMC MRD on day 21 from a different center, the same good prognosis value of MRD lower than 10-4at that time point was confirmed for EFS (p=0.03). Childhood ALL has become of relatively good prognosis with the progress in therapies. However, it is noteworthy that half the patients had detectable MRD at levels 1, 2 or 3, which probably prompted the clinicians to intensify treatment. However, below level 3, i.e.<10-4, FCM MRD on D21 is of excellent prognosis, even if detectable. In summary, this work demonstrates the feasibility of FCM evaluation on D21, with the advantage of not being complicated by the presence of hematogones. Moreover, interpretation remains delicate in morphology at this time point where BM smears may be very poor. FCM thereby provides precious early information on chemosensitivity with a single patient-adapted antibody combination. Disclosures No relevant conflicts of interest to declare." @default.
• W177056526 created "2016-06-24" @default.
• W177056526 creator A5007907029 @default.
• W177056526 creator A5020187382 @default.
• W177056526 creator A5022025860 @default.
• W177056526 creator A5024848689 @default.
• W177056526 creator A5031191977 @default.
• W177056526 creator A5038457477 @default.
• W177056526 creator A5050278979 @default.
• W177056526 creator A5058532201 @default.
• W177056526 creator A5077603727 @default.
• W177056526 creator A5081625864 @default.
• W177056526 creator A5083208635 @default.
• W177056526 date "2014-12-06" @default.
• W177056526 modified "2023-09-29" @default.
• W177056526 title "Value of Day 21 Flow Cytometry Minimal Residual Disease Assessment in Childhood Acute Lymphoblastic Leukemia (ALL) for Early Identification of Good Responders" @default.
• W177056526 doi "https://doi.org/10.1182/blood.v124.21.5358.5358" @default.
• W177056526 hasPublicationYear "2014" @default.
• W177056526 type Work @default.
• W177056526 sameAs 177056526 @default.
• W177056526 citedByCount "0" @default.
• W177056526 crossrefType "journal-article" @default.
• W177056526 hasAuthorship W177056526A5007907029 @default.
• W177056526 hasAuthorship W177056526A5020187382 @default.
• W177056526 hasAuthorship W177056526A5022025860 @default.
• W177056526 hasAuthorship W177056526A5024848689 @default.
• W177056526 hasAuthorship W177056526A5031191977 @default.
• W177056526 hasAuthorship W177056526A5038457477 @default.
• W177056526 hasAuthorship W177056526A5050278979 @default.
• W177056526 hasAuthorship W177056526A5058532201 @default.
• W177056526 hasAuthorship W177056526A5077603727 @default.
• W177056526 hasAuthorship W177056526A5081625864 @default.
• W177056526 hasAuthorship W177056526A5083208635 @default.
• W177056526 hasConcept C126322002 @default.
• W177056526 hasConcept C143998085 @default.
• W177056526 hasConcept C196166836 @default.
• W177056526 hasConcept C203014093 @default.
• W177056526 hasConcept C2776611710 @default.
• W177056526 hasConcept C2776694085 @default.
• W177056526 hasConcept C2776863199 @default.
• W177056526 hasConcept C2778461978 @default.
• W177056526 hasConcept C2779823535 @default.
• W177056526 hasConcept C2780007613 @default.
• W177056526 hasConcept C2781107101 @default.
• W177056526 hasConcept C2909962599 @default.
• W177056526 hasConcept C553184892 @default.
• W177056526 hasConcept C71924100 @default.
• W177056526 hasConceptScore W177056526C126322002 @default.
• W177056526 hasConceptScore W177056526C143998085 @default.
• W177056526 hasConceptScore W177056526C196166836 @default.
• W177056526 hasConceptScore W177056526C203014093 @default.
• W177056526 hasConceptScore W177056526C2776611710 @default.
• W177056526 hasConceptScore W177056526C2776694085 @default.
• W177056526 hasConceptScore W177056526C2776863199 @default.
• W177056526 hasConceptScore W177056526C2778461978 @default.
• W177056526 hasConceptScore W177056526C2779823535 @default.
• W177056526 hasConceptScore W177056526C2780007613 @default.
• W177056526 hasConceptScore W177056526C2781107101 @default.
• W177056526 hasConceptScore W177056526C2909962599 @default.
• W177056526 hasConceptScore W177056526C553184892 @default.
• W177056526 hasConceptScore W177056526C71924100 @default.
• W177056526 hasLocation W1770565261 @default.
• W177056526 hasOpenAccess W177056526 @default.
• W177056526 hasPrimaryLocation W1770565261 @default.
• W177056526 hasRelatedWork W1454471100 @default.
• W177056526 hasRelatedWork W206898877 @default.
• W177056526 hasRelatedWork W2339249965 @default.
• W177056526 hasRelatedWork W2357178742 @default.
• W177056526 hasRelatedWork W2361293117 @default.
• W177056526 hasRelatedWork W2365330342 @default.
• W177056526 hasRelatedWork W2377883329 @default.
• W177056526 hasRelatedWork W2392436082 @default.
• W177056526 hasRelatedWork W2523731185 @default.
• W177056526 hasRelatedWork W2553164987 @default.
• W177056526 hasRelatedWork W2554978362 @default.
• W177056526 hasRelatedWork W2556678145 @default.
• W177056526 hasRelatedWork W2569244230 @default.
• W177056526 hasRelatedWork W2586059224 @default.
• W177056526 hasRelatedWork W2589574462 @default.
• W177056526 hasRelatedWork W2966592462 @default.
• W177056526 hasRelatedWork W2986080996 @default.
• W177056526 hasRelatedWork W2986339664 @default.
• W177056526 hasRelatedWork W3030060885 @default.
• W177056526 hasRelatedWork W3032002953 @default.
• W177056526 isParatext "false" @default.
• W177056526 isRetracted "false" @default.
• W177056526 magId "177056526" @default.
• W177056526 workType "article" @default.